India’s Revised Schedule M requires pharmaceutical manufacturers to upgrade their understanding of quality, documentation, and manufacturing controls. The revised regulation focuses on the importance of Pharmaceutical Quality Systems (PQS), Quality Risk Management (QRM), data integrity, documentation, and digital systems control.
This creates a challenge for pharma companies using paper or hybrid Batch Manufacturing Records (BMRs). While it may be relatively easy to ensure that all necessary documents are present, it is equally important to guarantee that data is captured properly, recorded at the proper time, and ensuring its traceability during an inspection.
To fill this gap, AI-assisted BMRs can become crucial. It transforms paper documents and digital formats into a simplified process of control and audit.
See how this could work for your process. Talk to our experts.
Why Paper BMRs Still Create Problems
Paper BMRs have been part of pharmaceutical manufacturing for years, and there is a reason they have lasted this long.
Pharmaceutical companies have been using paper BMRs for years, but the problem starts when the same process must be repeated across large production volumes, multiple batches, and multiple teams.
Every entry, calculation, correction, signature, and reconciliation depends on someone. When something is missed, the issue may not become visible until the batch reaches QA.
Some of the common challenges include:
- Missing or delayed signatures and approvals
- Manual corrections and cross-outs
- Differences between approved BOM quantities and actual consumption
- Difficulty establishing when an entry was made or changed
- Large amounts of QA time spent checking routine documentation
Where AI-Assisted BMRs Can Make a Difference
Digitization should not simply take the BMR and convert it into a digital document. A more effective strategy will be to integrate BMR within a structured process through which information can be aggregated, verified, and flagged for further investigation.
AI can add value at this stage. Information can be collected via scanning, PDFs, structured manufacturing databases, and even via connected devices, which means that the entire record can be reviewed, not just individual entries.
Table of Contents
Improving Data Integrity
Individual user credentials, digital signatures, timestamps, role-based access, proper sequencing, and audit trails can all be incorporated into the process. Rather than having a person try to piece together what took place from a paper trail, the system will maintain a better history of the process.
The value of an electronic BMR is not simply that it is paperless. It is that the record itself can provide stronger evidence of what happened during manufacturing.
Ready to modernize your BMR process?
See how AI-assisted BMR review can strengthen data integrity, automate routine checks, and help QA focus on exceptions.
Helping QA Focus on Exceptions
Every BMR must be reviewed manually; a large part of QA’s effort goes into checking routine entries that may have no issues. A digital process can identify missing information, out-of-tolerance values, unexpected changes, or sequencing issues and bring those exceptions forward.
For manufacturers looking to increase production without adding the same level of manual review with every additional batch, that shift can be significant.
How to Approach BMR Digitization
Once the internal gaps are clear, manufacturers can choose one process where digitization can have an immediate impact. BOM reconciliation, electronic approvals, batch review, and data integrity controls are all potential starting points.
A phased approach could look like this:
- Evaluate the current process to recognize the major gaps in documentation and data integrity.
- Select a high-impact use case scenario as opposed to digitalizing everything.
- Link appropriate sources of information, from ERP, MES, and LIMS to equipment, and previous documents.
- Implement automated checks with the help of artificial intelligence technology to detect deviations and exceptions.
- Direct the exceptions to the appropriate teams for analysis and approval.
- Validate the process and expand it once the approach is proven.
Where AI Fits
AI should not be treated as a replacement for validated controls or human judgment in a regulated manufacturing environment.
AI becomes more useful when the information is more complex or spread across large volumes of documentation. It can help extract information from scanned BMRs, compare records, identify inconsistencies, and summarize exceptions for QA review.
Saxon AI provides a supporting layer within the quality process rather than a replacement for the people responsible for making quality decisions.
The Bottom Line
Revised Schedule M is raising the expectations around pharmaceutical manufacturing documentation in India. It is not only about whether a company has its BMR completed. It is rather about how effectively this document proves that data was gathered and processed in an appropriate way and that any changes can be properly tracked.
For those companies that have paper or mixed BMRs, digitization provides the solution. But the objective should not be to make the existing process digital just for the sake of it.
That is where AI-assisted BMR digitization can move beyond compliance and become part of a more efficient, transparent, and connected approach to pharmaceutical manufacturing.
Turn BMR digitization into a smarter QA workflow.
Discover how Saxon AI helps pharma teams extract, validate, and review BMR data while keeping QA in control.